Terry-Ann Burrell, Director: Recursion Pharmaceuticals RXRX Sell · Filed 23/07/14

Trade details

Type: Insider sale
Amount: $104,182.25
Shares · price: 8,275 sh · $12.59 a share
Held after: 54,847 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Terry-Ann BurrellDirector
Trade date: 23/07/13
Filed: 23/07/14
Days to filing: 1 days

Sold 13.1% of holdings

Share of holding sold: 13.1%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/06/13~23/08/12

Terry-Ann Burrell's recent trades

Terry-Ann BurrellCFO
Sell10b5-1 planBeam Therapeutics
Sell10b5-1 plan
Beam Therapeutics
BEAM
$174.9K
5,446 sh
$174.9K
Filed 24/04/03
Traded 24/04/01
Terry-Ann BurrellDirector
SellRecursion Pharmaceuticals
Sell
Recursion Pharmaceuticals
RXRX
$948.6K
78,071 sh
$948.6K
Filed 23/07/14
Traded 23/07/12
Terry-Ann BurrellDirector
SellRecursion Pharmaceuticals
Sell
Recursion Pharmaceuticals
RXRX
$273.4K
24,302 sh
$273.4K
Filed 23/07/14
Traded 23/07/12
Terry-Ann BurrellDirector
SellRecursion Pharmaceuticals
Sell
Recursion Pharmaceuticals
RXRX
$44.5K
3,157 sh
$44.5K
Filed 23/07/14
Traded 23/07/12
Terry-Ann BurrellDirector
SellRecursion Pharmaceuticals
Sell
Recursion Pharmaceuticals
RXRX
$42.1K
3,195 sh
$42.1K
Filed 23/07/14
Traded 23/07/12